Get the Stockscreener App
7.8699
1.85%
0.1599
Fennec Pharmaceuticals Inc stock is traded at $7.8699, with a volume of 52,335.
It is up +1.85% in the last 24 hours and down -2.93% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$7.71
Open:
$7.69
24h Volume:
52,335
Relative Volume:
0.35
Market Cap:
$268.45M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-12.90
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
+6.26%
1M Performance:
-2.93%
6M Performance:
-9.01%
1Y Performance:
+19.89%
1-Day Range:
$7.68
$7.95
1-Week Range:
$7.40
$7.95
52-Week Range:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.86 | 263.32M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.94 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.19 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.84 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.23 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.08 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Piper Sandler | Overweight |
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
View All
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock - Defense World
Analyst Upgrade: Is Oculis Holding AG Equity Warrant forming higher highs and higher lowsTrade Entry Summary & Fast Momentum Entry Tips - baoquankhu1.vn
CEO Change: Why is Fennec Pharmaceuticals Inc stock going downJuly 2025 Snapshot & AI Driven Price Predictions - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$10,350,000.00 in Stock - MarketBeat
(FRX) Financial Trading Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily
Does Fennec Pharmaceuticals Inc. have a sustainable dividendNew Guidance & Free Growth Oriented Trading Recommendations - bollywoodhelpline.com
(FRX) Daily Stock Insights (FRX:CA) - Stock Traders Daily
Behavioral Patterns of FENC and Institutional Flows - Stock Traders Daily
Wall Street Zen Downgrades Adherex Technologies (NASDAQ:FENC) to Buy - MarketBeat
Buyback Watch: What is the long term forecast for Fennec Pharmaceuticals Inc stockJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fennec Pharmaceuticals (TSX:FRX) Price Target Increased by 10.41% to 21.57 - Nasdaq
(FRX) Strategic Investment Report (FRX:CA) - Stock Traders Daily
Adherex Technologies (NASDAQ:FENC) Now Covered by Piper Sandler - Defense World
How Fennec Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Spike Watch & Smart Investment Allocation Insights - Улправда
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com South Africa
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating - Investing.com India
Can Fennec Pharmaceuticals Inc. (RV41) stock stage a strong rebound this quarterJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - Улправда
Is Fennec Pharmaceuticals Inc. (RV41) stock attractive for growth fundsEarnings Miss & Safe Entry Point Identification - Улправда
Is Fennec Pharmaceuticals Inc. (RV41) stock a safe buy pre earningsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Published on: 2026-01-08 23:30:09 - Улправда
Can Fennec Pharmaceuticals Inc. stock continue upward trendJuly 2025 Update & Weekly High Momentum Picks - Улправда
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Yahoo Finance
(FRX) Pivots Trading Plans and Risk Controls (FRX:CA) - Stock Traders Daily
Aug Final Week: Is Fennec Pharmaceuticals Inc RV41 stock undervalued by metricsTrade Volume Report & Weekly High Return Stock Forecasts - moha.gov.vn
Is Fennec Pharmaceuticals Inc RV41 a good long term investmentStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Fennec Pharmaceuticals Inc (TSX:FRX) Slipped Under Its Trend Key Levels Matter - Kalkine Media
(FRX) On The My Stocks Page (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
Aug Opening: Can Fennec Pharmaceuticals Inc RV41 stock stage a strong rebound this quarterPortfolio Gains Summary & Safe Swing Trade Setups - Bộ Nội Vụ
Adherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Stock - Defense World
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals Says Southpoint Capital Sold 1 Million Shares - MarketScreener
Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times
Southpoint Capital Advisors controls 2.7 million common shares, 8% of outstanding common shares of Fennec - MarketScreener
Southpoint Trims Stake in Fennec Pharmaceuticals to 8% - TipRanks
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewswire Inc.
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fennec Pharmaceuticals Inc Stock (FENC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Andrade Robert | CHIEF FINANCIAL OFFICER |
Jan 15 '26 |
Option Exercise |
2.45 |
10,000 |
24,500 |
201,100 |
| Andrade Robert | CHIEF FINANCIAL OFFICER |
Jan 07 '26 |
Option Exercise |
2.45 |
14,184 |
34,751 |
191,100 |
| Raykov Rosty | Director |
Jan 02 '26 |
Option Exercise |
2.45 |
15,598 |
38,215 |
98,332 |
| Raykov Rosty | Director |
Jan 02 '26 |
Sale |
7.60 |
10,312 |
78,371 |
88,020 |
2.05%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):